Sanger sequencing plays an important role in mapping DNA sequences and gaining insights into the genetics of various diseases. Some of the key applications of Sanger sequencing include identifying and mapping of the human genome, clinical diagnostics of genetic disorders, forensic analysis, and targeted re-sequencing projects. The non-commercial open-source databases created with Sanger sequencing technology have significantly contributed to advances in life sciences research.
The Global Sanger Sequencing Market is estimated to be valued at US$ 10,130.6 Mn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global Sanger Sequencing Market are Eurofins Scientific, CeMIA, Fasteris SA, GENEWIZ, GenHunter Corporation, GenScript, LGC Biosearch Technologies, Nucleics, Quintara Biosciences, SciGenom Labs Pvt. Ltd, StarSEQ GmbH, Thermo Fisher Scientific Inc., QIAGEN, Promega Corporation, and Source BioScience. Eurofins Scientific and Thermo Fisher Scientific Inc capture over 30% of the market share due to their diversified product portfolio and strong global presence.
The rising application of Sanger sequencing in clinical diagnostics of genetic disorders is a major factor driving the growth of this market. Sanger sequencing helps in the identification of single-nucleotide variants and small mutations responsible for genetic disorders. Moreover, the continuous decline in the cost of sequencing has made Sanger sequencing an affordable method for clinical diagnosis, further boosting the market growth.
Technological advancements including automated sequencing platforms, web-based sequencing analysis tools, and workflow management software are augmenting the capabilities of Sanger sequencing. The development of enhanced chemistries for fluorescence-based sequencing and instruments with higher throughput is expanding the application range of Sanger sequencing.
Fastest Growing Regional Market for Global Sanger Sequencing Market
Asia Pacific is anticipated to be the fastest growing regional market for Sanger sequencing during the forecast years. Rising penetration of next-generation sequencing technologies is driving the demand for Sanger sequencing in emerging Asia Pacific countries. Further, large population with increasing incidence of genetic disorders and growth in medical tourism are propelling diagnostic applications of sequencing. Substantial funding for agricultural and clinical research from governments and private entities offers significant opportunities. In addition, presence of low-cost skilled workforces is attracting sequencing product manufacturers and service providers to set up facilities in Asia Pacific. All these factors will significantly contribute to the fast growth of this regional market in the coming years.
Get more insights on Sanger Sequencing Market
